Presentation of cryptic peptides by MHC class i is enhanced by inflammatory stimuli

Journal of Immunology

Volumn 197, Issue 8, 2016, Pages 2981-2991

  Prasad, Sharanya ^a   Starck, Shelley R ^a   Shastri, Nilabh ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CRYPTIC PEPTIDE; CYTOKINE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; PEPTIDE; TOLL LIKE RECEPTOR; UNCLASSIFIED DRUG; AUTACOID; HLA ANTIGEN CLASS 2; VIRUS ANTIGEN;

ANIMAL CELL; ANIMAL TISSUE; ANTIGEN PRESENTATION; ANTIGEN RECOGNITION; ARTICLE; CANCER CELL; CELL SURFACE; CONTROLLED STUDY; CYTOKINE RELEASE; CYTOTOXIC T LYMPHOCYTE; IMMUNE SYSTEM; INFLAMMATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS; RNA TRANSLATION; SIGNAL TRANSDUCTION; START CODON; VIRUS INFECTION; ANIMAL; C57BL MOUSE; CELL CULTURE; HERPES VIRUS INFECTION; IMMUNOLOGY; MACROPHAGE; METABOLISM; MUROMEGALOVIRUS; TRANSGENIC MOUSE;

ANIMALS; ANTIGEN PRESENTATION; ANTIGENS, VIRAL; CELLS, CULTURED; CYTOKINES; HERPESVIRIDAE INFECTIONS; HISTOCOMPATIBILITY ANTIGENS CLASS II; INFLAMMATION; INFLAMMATION MEDIATORS; MACROPHAGES; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MUROMEGALOVIRUS; PEPTIDES; PROTEIN BIOSYNTHESIS; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTORS;

EID: 84991497882     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1502045     Document Type: Article

References (40)

1. Blum, J. S., P. A. Wearsch, and P. Cresswell. 2013. Pathways of antigen processing. Annu. Rev. Immunol. 31: 443-473.
2. Neefjes, J., M. L. Jongsma, P. Paul, and O. Bakke. 2011. Towards a systems understanding of MHC class I and MHC class II antigen presentation. Nat. Rev. Immunol. 11: 823-836.
3. Shastri, N., S. Schwab, and T. Serwold. 2002. Producing nature's gene-chips: the generation of peptides for display by MHC class I molecules. Annu. Rev. Immunol. 20: 463-493.
4. Yewdell, J. W., and C. V. Nicchitta. 2006. The DRiP hypothesis decennial: support, controversy, refinement and extension. Trends Immunol. 27: 368-373.
5. Farfán-Arribas, D. J., L. J. Stern, and K. L. Rock. 2012. Using intein catalysis to probe the origin of major histocompatibility complex class I-presented peptides. Proc. Natl. Acad. Sci. USA 109: 16998-17003.
6. Yewdell, J. W. 2011. DRiPs solidify: progress in understanding endogenous MHC class I antigen processing. Trends Immunol. 32: 548-558.
7. Malarkannan, S., M. Afkarian, and N. Shastri. 1995. A rare cryptic translation product is presented by Kb major histocompatibility complex class I molecule to alloreactive T cells. J. Exp. Med. 182: 1739-1750.
8. Cardinaud, S., A. Moris, M. Février, P. S. Rohrlich, L. Weiss, P. Langlade-Demoyen, F. A. Lemonnier, O. Schwartz, and A. Habel. 2004. Identification of cryptic MHC Irestricted epitopes encoded by HIV-1 alternative reading frames. J. Exp. Med. 199: 1053-1063.
9. Goodenough, E., T. M. Robinson, M. B. Zook, K. M. Flanigan, J. F. Atkins, M. T. Howard, and L. C. Eisenlohr. 2014. Cryptic MHC class Ibinding peptides are revealed by aminoglycoside-induced stop codon read-through into the 39 UTR. Proc. Natl. Acad. Sci. USA 111: 5670-5675.
10. + cytotoxic T cell epitopes. PLoS One 6: e26517.
11. Zook, M. B., M. T. Howard, G. Sinnathamby, J. F. Atkins, and L. C. Eisenlohr. 2006. Epitopes derived by incidental translational frameshifting give rise to a protective CTL response. J. Immunol. 176: 6928-6934.
12. Malarkannan, S., T. Horng, P. P. Shih, S. Schwab, and N. Shastri. 1999. Presentation of out-of-frame peptide/MHC class I complexes by a novel translation initiation mechanism. Immunity 10: 681-690.
13. Schwab, S. R., J. A. Shugart, T. Horng, S. Malarkannan, and N. Shastri. 2004. Unanticipated antigens: translation initiation at CUG with leucine. PLoS Biol. 2: e366.
14. Starck, S. R., and N. Shastri. 2011. Non-conventional sources of peptides presented by MHC class I. Cell. Mol. Life Sci. 68: 1471-1479.
15. Cardinaud, S., G. Consiglieri, R. Bouziat, A. Urrutia, S. Graff-Dubois, S. Fourati, I. Malet, J. Guergnon, A. Guihot, C. Katlama, et al. 2011. CTL escape mediated by proteasomal destruction of an HIV-1 cryptic epitope. PLoS Pathog. 7: e1002049.
16. Rutkowski, M. R., O. Ho, and W. R. Green. 2009. Defining the mechanism(s) of protection by cytolytic CD8 T cells against a cryptic epitope derived from a retroviral alternative reading frame. Virology 390: 228-238.
17. Garrison, K. E., S. Champiat, V. A. York, A. T. Agrawal, E. G. Kallas, J. N. Martin, F. M. Hecht, S. G. Deeks, and D. F. Nixon. 2009. Transcriptional errors in human immunodeficiency virus type 1 generate targets for T-cell responses. Clin. Vaccine Immunol. 16: 1369-1371.
18. Li, C., K. Goudy, M. Hirsch, A. Asokan, Y. Fan, J. Alexander, J. Sun, P. Monahan, D. Seiber, J. Sidney, et al. 2009. Cellular immune response to cryptic epitopes during therapeutic gene transfer. Proc. Natl. Acad. Sci. USA 106: 10770-10774.
19. Andersen, R. S., S. R. Andersen, M. D. Hjortsø, R. Lyngaa, M. Idorn, T. M. Køllgård, O. Met, P. Thor Straten, and S. R. Hadrup. 2013. High frequency of T cells specific for cryptic epitopes in melanoma patients. OncoImmunology 2: e25374.
20. Weinzierl, A. O., D. Maurer, F. Altenberend, N. Schneiderhan-Marra, K. Klingel, O. Schoor, D. Wernet, T. Joos, H. G. Rammensee, and S. Stevanović. 2008. A cryptic vascular endothelial growth factor T-cell epitope: identification and characterization by mass spectrometry and T-cell assays. Cancer Res. 68: 2447-2454.
21. Schwab, S. R., K. C. Li, C. Kang, and N. Shastri. 2003. Constitutive display of cryptic translation products by MHC class I molecules. Science 301: 1367-1371.
22. Starck, S. R., V. Jiang, M. Pavon-Eternod, S. Prasad, B. McCarthy, T. Pan, and N. Shastri. 2012. Leucine-tRNA initiates at CUG start codons for protein synthesis and presentation by MHC class I. Science 336: 1719-1723.
23. Starck, S. R., Y. Ow, V. Jiang, M. Tokuyama, M. Rivera, X. Qi, R. W. Roberts, and N. Shastri. 2008. A distinct translation initiation mechanism generates cryptic peptides for immune surveillance. PLoS One 3: e3460.
24. Karttunen, J., S. Sanderson, and N. Shastri. 1992. Detection of rare antigenpresenting cells by the lacZ T-cell activation assay suggests an expression cloning strategy for T-cell antigens. Proc. Natl. Acad. Sci. USA 89: 6020-6024.
25. Malarkannan, S., P. P. Shih, P. A. Eden, T. Horng, A. R. Zuberi, G. Christianson, D. Roopenian, and N. Shastri. 1998. The molecular and functional characterization of a dominant minor H antigen, H60. J. Immunol. 161: 3501-3509.
26. Serwold, T., S. Gaw, and N. Shastri. 2001. ER aminopeptidases generate a unique pool of peptides for MHC class I molecules. Nat. Immunol. 2: 644-651.
27. Mendoza, L. M., P. Paz, A. Zuberi, G. Christianson, D. Roopenian, and N. Shastri. 1997. Minors held by majors: the H13 minor histocompatibility locus defined as a peptide/MHC class I complex. Immunity 7: 461-472.
28. Aragón, T., S. de la Luna, I. Novoa, L. Carrasco, J. Ortń, and A. Nieto. 2000. Eukaryotic translation initiation factor 4GI is a cellular target for NS1 protein, a translational activator of influenza virus. Mol. Cell. Biol. 20: 6259-6268.
29. Wang, X., and D. G. Chen. 2009. Recombinant murine cytomegalovirus vector activates human monocyte-derived dendritic cells in a NF-kB dependent pathway. Mol. Immunol. 46: 3462-3465.
30. Kawai, T., and S. Akira. 2010. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat. Immunol. 11: 373-384.
31. Cláudio, N., A. Dalet, E. Gatti, and P. Pierre. 2013. Mapping the crossroads of immune activation and cellular stress response pathways. EMBO J. 32: 1214-1224.
32. Qian, Z., B. Xuan, T. J. Chapa, N. Gualberto, and D. Yu. 2012. Murine cytomegalovirus targets transcription factor ATF4 to exploit the unfolded-protein response. J. Virol. 86: 6712-6723.
33. Katsoulidis, E., Y. Li, H. Mears, and L. C. Platanias. 2005. The p38 mitogenactivated protein kinase pathway in interferon signal transduction. J. Interferon Cytokine Res. 25: 749-756.
34. Dunne, A., and L. A. O'Neill. 2003. The interleukin-1 receptor/Toll-like receptor superfamily: signal transduction during inflammation and host defense. Sci. STKE 2003: re3.
35. O'Neill, L. A., and A. G. Bowie. 2007. The family of five: TIR-domaincontaining adaptors in Toll-like receptor signalling. Nat. Rev. Immunol. 7: 353-364.
36. Bhattacharyya, S., D. E. Brown, J. A. Brewer, S. K. Vogt, and L. J. Muglia. 2007. Macrophage glucocorticoid receptors regulate Toll-like receptor 4-mediated inflammatory responses by selective inhibition of p38 MAP kinase. Blood 109: 4313-4319.
37. Jarnicki, A. G., H. Conroy, C. Brereton, G. Donnelly, D. Toomey, K. Walsh, C. Sweeney, O. Leavy, J. Fletcher, E. C. Lavelle, et al. 2008. Attenuating regulatory T cell induction by TLR agonists through inhibition of p38 MAPK signaling in dendritic cells enhances their efficacy as vaccine adjuvants and cancer immunotherapeutics. J. Immunol. 180: 3797-3806.
38. Kang, T., N. H. Kwon, J. Y. Lee, M. C. Park, E. Kang, H. H. Kim, T. J. Kang, and S. Kim. 2012. AIMP3/p18 controls translational initiation by mediating the delivery of charged initiator tRNA to initiation complex. J. Mol. Biol. 423: 475-481.
39. Park, S. G., E.-C. Choi, and S. Kim. 2010. Aminoacyl-tRNA synthetaseinteracting multifunctional proteins (AIMPs): a triad for cellular homeostasis. IUBMB Life 62: 296-302.
40. Han, J. M., B. J. Park, S. G. Park, Y. S. Oh, S. J. Choi, S. W. Lee, S. K. Hwang, S. H. Chang, M. H. Cho, and S. Kim. 2008. AIMP2/p38, the scaffold for the multi-tRNA synthetase complex, responds to genotoxic stresses via p53. Proc. Natl. Acad. Sci. USA 105: 11206-11211.